Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing. // Biochimica et Biophysica Acta: General Subjects. – URL: https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all
Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing. Biochimica et Biophysica Acta: General Subjects. https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all
“Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing.” Biochimica et Biophysica Acta: General Subjects.
@article{article11010,
title = {Dihydroartemisinin inhibits Epstein-Barr virus reactivation and replication targeting lytic proteins: insights for drug repurposing},
journal = {Biochimica et Biophysica Acta: General Subjects},
url = {https://www.sciencedirect.com/science/article/pii/S0166354226001725?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...